We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Investigation of Hepatitis B and Hepatitis C in Taiwan

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00946010
First Posted: July 24, 2009
Last Update Posted: January 24, 2011
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
National Taiwan University Hospital
April 1, 2008
July 24, 2009
January 24, 2011
April 2008
August 2010   (Final data collection date for primary outcome measure)
genotype and DNA level or RNA level of HBV and HCV virus [ Time Frame: once during Mar. 2008- Jan. 2011 ]
Same as current
Complete list of historical versions of study NCT00946010 on ClinicalTrials.gov Archive Site
Not Provided
Not Provided
Not Provided
Not Provided
 
Investigation of Hepatitis B and Hepatitis C in Taiwan
Investigation of Hepatitis B and Hepatitis C in Taiwan
The purpose of this study is to investigate the differences of genotypes of hepatitis B and hepatitis C in Taiwan.
The purpose of this study is investigating the differences of genotypes and DNA level or RNA level of hepatitis B and hepatitis C in Taiwan.
Observational
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Not Provided
Retention:   Samples With DNA
Description:
10ml blood was sampled and then serum was be retained.
Non-Probability Sample
People Born before 1985/01/01 who live in Taiwan are HBV or HCV pateints.
  • Hepatitis B
  • Hepatitis C
Biological: blood sampling and abdominal sonography
10cc blood sampling and abdominal sonography
Other Name: 10cc blood sampling and abdominal sonography
1
Click here for more information about this study: Investigation of Hepatitis B and Hepatitis C in Taiwan
Intervention: Biological: blood sampling and abdominal sonography
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
6228
January 2011
August 2010   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Born before 1985/01/01
  • HBV or HCV carriers

Exclusion Criteria:

Sexes Eligible for Study: All
23 Years and older   (Adult, Senior)
Yes
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
 
NCT00946010
200801059R
Yes
Not Provided
Not Provided
National Taiwan University Hospital
National Taiwan University Hospital
Not Provided
Study Chair: Jin-Chuan Sheu, M.D. P.H.D. National Taiwan University Hospital
National Taiwan University Hospital
January 2011